Sugi Predict

Sugi Predict / Compounds / SCHEMBL2995272

SCHEMBL2995272

SCHEMBL2995272

COc1ccccc1-c1ccnc(Nc2cccc(CS(=O)(=O)N(C)CCO)c2)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK9 P50750 16/20 0.61
▸ GSK3A P49840 3/20 0.61
▸ CDK5 Q00535 3/20 0.61
▸ MAP4K4 O95819 2/20 0.61
▸ GSK3B P49841 2/20 0.61
▸ FLT3 P36888 2/20 0.61
▸ ABL1 P00519 2/20 0.61
▸ PDGFRB P09619 2/20 0.61
▸ AURKA O14965 1/20 0.61
▸ LCK P06239 1/20 0.61
▸ MET P08581 1/20 0.61
▸ FGFR1 P11362 1/20 0.61
▸ FLT1 P17948 1/20 0.61
▸ KDR P35968 1/20 0.61
▸ MAPK8 P45983 1/20 0.61
▸ MAPK9 P45984 1/20 0.61
▸ ACVR1 Q04771 1/20 0.61
▸ MST1R Q04912 1/20 0.61
▸ TYRO3 Q06418 1/20 0.61
▸ NTRK2 Q16620 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3013163 0.89 CDK9 (0.67) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL3010489 0.89 CDK9 (0.47) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL2995165 0.86 CDK9 (0.66) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL3005059 0.85 CDK9 (0.65) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL3003557 0.84 CDK9 (0.50) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL8515368 0.84 CDK9 (0.71) CDK9GSK3ACDK5MAP4K4CLK4
SCHEMBL3005997 0.83 CDK9 (0.70) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL3005881 0.82 CDK9 (0.68) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL3008795 0.79 CDK9 (0.63) CDK9GSK3ACDK5MAP4K4GSK3B
SCHEMBL16564577 0.76 CDK9 (0.77) CDK9GSK3ACDK5MAP4K4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137163-B1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2015-03-18 — — EP claimed
US-8436007-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2013-05-07 — — US claimed
US-20100184789-A1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2010-07-22 — — US claimed
EP-2137163-B1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2015-03-18 — — EP disclosed
EP-2137163-B1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2015-03-18 — — EP disclosed
US-8436007-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2013-05-07 — — US disclosed
US-8436007-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2013-05-07 — — US disclosed
US-20100184789-A1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2010-07-22 — — US disclosed
US-20100184789-A1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2010-07-22 — — US disclosed
US-20100184789-A1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2010-07-22 — — US disclosed
WO-2008129070-A1 INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2008-10-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100184789-A1 INHIBITORS OF PROTEIN KINASES CDK1, CDK2, CDK5 CDK9 11/4885GSK3A 292/4885CDK5 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.